Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Tradedoubler - Something new on the Western front

TradeDoubler

Redeye updates its estimates and valuation for Tradedoubler following the Q1 2025 report. While sales came in about 6% below our estimates, with 2% y/y growth due to a challenging market, Metapic's emergence helped drive margins, with gross profit up 11% compared to the same period in 2024. We expect market conditions to become progressively more favourable throughout the year, and, coupled with an active M&A ambition, its first US office, and low single-digit EBIT multiples, we see favorable conditions ahead. Our sales estimates are trimmed somewhat following the weaker-than-expected growth, resulting in a very slight downward revision to our fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Tradedoubler - Something new on the Western front

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.